Coronavirus disease 2019<unk> -19) is a rapidly expanding global pandemic which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Myocardial<unk>  presented by high level of cardiac troponin is a common manifestation in<unk> -19. The exact pathogenesis of myocardial<unk>  in<unk> -19 is not clear yet. However, systemic inflammation, hypoxemia, vasopressor requirement, thrombophilia have been proposed as the underlying mechanisms of myocardial<unk> . Factors<unk>  with myocardial<unk>  including age, creatinine, multisystem organ failure were similar in both<unk> -19 and non<unk> -19 patients. Myocardial<unk>  was less common in severe<unk> -19 in comparisson with ARDS without<unk> -19. However, it was<unk>  with poor outcome  in critically ill<unk> -19 patients and increased risk of intubation and death. So, Myocardial<unk>  can be the manifestation of underlying critically illness and multisystem organ dysfunction, especially concomitant renal dysfunction, as well as thrombotic complications among<unk> -19 patients.
COVID-19-associated myocardial injury
COVID-19-associated myocardial infarction
COVID-19-associated cardiogenic shock
COVID-19-associated cytokine storm
COVID-19-associated heart failure
COVID-19-associated myocarditis
COVID-19-associated stress cardiomyopathy
COVID-19-associated arrhythmia and conduction system disease